LEP and COVID-19: Elevated levels of circulating leptin are generally attributed to the development of leptin resistance (Zieba et al., 2020), a hallmark of obesity, which is already recognized as a risk factor for severe COVID-19 (Rebello et al., 2020; Maurya et al., 2021).